cemka > Publications > 2006

Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    StratĂ©gie diagnostique de l’infection par le VHC en mĂ©decine gĂ©nĂ©rale : Etats des lieux, nature des obstacles rencontrĂ©s – Etude GYMKHANA 1 (2Ăšme partie)

    AUBERT JP, BOUEE S, BENTATA M, COMPAGNON M, ELGHOZI B, LIVROZET JM, MECHALI D, PERDRIEAU F, PY AM, ROZEMBAUM W, TAULERA O, WAJSBROT A

    Rev Prat - Médecine Générale ; 20(726/727):386-391

  • Pharmaco-EpidĂ©miologie

    Seroprevalence of Varicella in the French Population

    KHOSHNOOD B, DEBRUYNE M, LANCON F, EMERY C, FAGNANI F, DURAND I, FLORET D

    Pediatr Infect Dis J ; 25(1):41-44

  • Pharmaco-EpidĂ©miologie

    Prevalence of visual impairment in relation to the number of ophtalmologists in a given area : a nationwide approach

    LAFUMA A, BREZIN A, FAGNANI F, MESBAH M, BERDEAUX G

    Health and Quality of Life Outcomes ; 4(34)

  • Économie de la santĂ©

    Nonmedical economic consequences attribuables to visual impairment nation-wide approach in France

    LAFUMA A, BREZIN A, FAGNANI F, MIMAUD V, MESBAH M, BERDEAUX G

    Eur J Health Econom ; 7(3):158-164

  • SantĂ© publique

    Management of innovative medicines in hospitals: an international comparison

    LAFUMA A, TILLEUL P

    EJHPP Practice ; 12(1):26-27

  • SantĂ© publique

    La nécessaire clarification de la place des réseaux de santé

    SANNINO N, DONIO V

    FiliÚres & Réseaux 2 Santé ; (7):44-45

  • Pharmaco-EpidĂ©miologie

    Human papillomavirus testing with a liquid-based system : feasibility and comparison with reference diagnoses

    BERGERON C, CAS F, FAGNANI F, DIDAILLER-LAMBERT F, POVEDA JD

    Acta Cytol ; 50(1):16-22

  • Économie de la santĂ©

    Evaluation of non-medical costs associated with visual impairment in four European countries – France, Italy, Germany and the UK

    LAFUMA A, BREZIN A, LAPATRIELLO S, HIEKE K, HUTCHINSON J, MIMAUD V, BERDEAUX G

    Pharmacoeconomics ; 24(2):193-205

  • Économie de la santĂ©

    Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries

    BOUEE S, LAFUMA A, FAGNANI F, MEUNIER PJ, REGINSTER JY

    Rheumatol Int ; 26(12):1063-72

  • Économie de la santĂ©

    Estimated annual costs of prophylaxis and treatment of venous thromboembolic events associated with major orthopedic surgery in France

    TILLEUL P, LAFUMA A, COLIN X, OZIER Y

    Clin Appl Thromb Hemost ; 12(4):473-484

  • Pharmaco-EpidĂ©miologie

    ENVOL study on the medical management of varicella and its complications in French ambulatory care

    EMERY C, LANCON F,  FAGNANI F, PECHEVIS M, DURAND I, FLORET D

    Med Mal Infect ; 36(2):92-98

  • Économie de la santĂ©

    Cervical cancer screening and associated treatment costs in France

    BERGERON C, BREUGELMANS JG, BOUEE S, LORANS C, BENARD S, REMY V

    Gynécol Obstét Fertil ; 34:1036-1042

  • SantĂ© publique

    Bases d’une rĂ©gulation dĂ©mographique pour une spĂ©cialitĂ© chirurgicale : Les Chirurgiens OrthopĂ©distes en France

    CATON J, DUBURCQ A

    Revue de Chirurgie OrthopĂ©dique et RĂ©paratrice de l’Appareil ; 92(8):818-826

  • Pharmaco-EpidĂ©miologie

    Assessment of human papillomavirus testing with a liquid-based Cyto-screen (Âź) system for women with atypical squamous cells of undetermined significance effect of age

    BERGERON C, CAS F, FAGNANI F, CONTREPAS A, WADIER R, POVEDA JD

    Gynécol Obstét Fertil ; 34(4):312-316

  • Pharmaco-EpidĂ©miologie

    Air, pollution et cancer : baromĂštre de pollutions en France

    NEROME S, QUOIX E, DUBURCQ A

    Carnet de routes-Editions Bash ; 1-17